These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28550801)
21. The NK-1 receptor: a new target in cancer therapy. Muñoz M; Rosso M; Coveñas R Curr Drug Targets; 2011 Jun; 12(6):909-21. PubMed ID: 21226668 [TBL] [Abstract][Full Text] [Related]
22. Cancer progression and substance P. Coveñas R; Muñoz M Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838 [TBL] [Abstract][Full Text] [Related]
23. The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer? Muñoz M; Coveñas R Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32962202 [TBL] [Abstract][Full Text] [Related]
24. NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011. Muñoz M; Martinez-Armesto J; Coveñas R Expert Opin Ther Pat; 2012 Jul; 22(7):735-46. PubMed ID: 22697287 [TBL] [Abstract][Full Text] [Related]
25. Advances in the research and application of neurokinin-1 receptor antagonists. Hong X; Ma J; Zheng S; Zhao G; Fu C J Zhejiang Univ Sci B; 2024 Feb; 25(2):91-105. PubMed ID: 38303494 [TBL] [Abstract][Full Text] [Related]
26. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605 [TBL] [Abstract][Full Text] [Related]
27. Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration. Dong J; Feng F; Xu G; Zhang H; Hong L; Yang J Gene; 2015 Apr; 560(2):205-10. PubMed ID: 25659767 [TBL] [Abstract][Full Text] [Related]
28. Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic Approach. Muñoz M; Coveñas R Anticancer Agents Med Chem; 2019; 19(1):92-100. PubMed ID: 29692265 [TBL] [Abstract][Full Text] [Related]
29. Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy? Robinson P; Coveñas R; Muñoz M Curr Med Chem; 2023; 30(16):1798-1812. PubMed ID: 35959620 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells. Dikmen M; Gökhaner G; Cantürk Z Anticancer Drugs; 2019 Aug; 30(7):e0769. PubMed ID: 31306152 [TBL] [Abstract][Full Text] [Related]
31. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload. Ge C; Huang H; Huang F; Yang T; Zhang T; Wu H; Zhou H; Chen Q; Shi Y; Sun Y; Liu L; Wang X; Pearson RB; Cao Y; Kang J; Fu C Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19635-19645. PubMed ID: 31488714 [TBL] [Abstract][Full Text] [Related]
32. N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis. Sirianni AC; Jiang J; Zeng J; Mao LL; Zhou S; Sugarbaker P; Zhang X; Li W; Friedlander RM; Wang X J Neurochem; 2015 Sep; 134(5):956-68. PubMed ID: 26031348 [TBL] [Abstract][Full Text] [Related]
33. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320 [TBL] [Abstract][Full Text] [Related]
34. NK-1 as a melanoma target. Muñoz M; Bernabeu-Wittel J; Coveñas R Expert Opin Ther Targets; 2011 Jul; 15(7):889-97. PubMed ID: 21592000 [TBL] [Abstract][Full Text] [Related]
35. Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues. Borrego JF; Huelsmeyer MK; Pinkerton ME; Muszynski JL; Miller SA; Kurzman ID; Vail DM Vet Comp Oncol; 2016 Jun; 14(2):210-24. PubMed ID: 24751104 [TBL] [Abstract][Full Text] [Related]
36. Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists. Molinos-Quintana A; Trujillo-Hacha P; Piruat JI; Bejarano-García JA; García-Guerrero E; Pérez-Simón JA; Muñoz M Invest New Drugs; 2019 Feb; 37(1):17-26. PubMed ID: 29721755 [TBL] [Abstract][Full Text] [Related]
37. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model. Li W; Fotinos A; Wu Q; Chen Y; Zhu Y; Baranov S; Tu Y; Zhou EW; Sinha B; Kristal BS; Wang X Neurobiol Dis; 2015 Aug; 80():93-103. PubMed ID: 25986728 [TBL] [Abstract][Full Text] [Related]
38. Varicella Zoster Virus Induces Nuclear Translocation of the Neurokinin-1 Receptor, Promoting Lamellipodia Formation and Viral Spread in Spinal Astrocytes. Bubak AN; Como CN; Blackmon AM; Frietze S; Mescher T; Jones D; Cohrs RJ; Paucek P; Baird NL; Nagel MA J Infect Dis; 2018 Sep; 218(8):1324-1335. PubMed ID: 29788447 [TBL] [Abstract][Full Text] [Related]
39. The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer. Martín-García D; Téllez T; Redondo M; García-Aranda M Curr Med Chem; 2024; 31(39):6487-6509. PubMed ID: 37861026 [TBL] [Abstract][Full Text] [Related]
40. Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231. Bigioni M; Benzo A; Irrissuto C; Maggi CA; Goso C Anticancer Drugs; 2005 Nov; 16(10):1083-9. PubMed ID: 16222150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]